Randomized Controlled Trial

. 2020 Dec 10;150(12):3161-3170.

doi: 10.1093/jn/nxaa289.

Metabolic Syndrome Features and Excess Weight Were Inversely Associated with Nut Consumption after 1-Year Follow-Up in the PREDIMED-Plus Study

Alicia Julibert^{1

2

3}, Maria Del Mar Bibiloni^{1

2

3}, Laura Gallardo-Alfaro^{1

2

3}, Manuela Abbate^{1

2

3}, Miguel Á Martínez-González^{1

4

5}, Jordi Salas-Salvadó^{1

6}, Dolores Corella^{1

7}, Montse Fitó^{1

8}, J Alfredo Martínez^{1

9

10}, Ángel M Alonso-Gómez^{1

11}, Julia Wärnberg^{1

12}, Jesús Vioque^{13

14}, Dora Romaguera^{1

3}, José Lopez-Miranda^{1

15}, Ramon Estruch^{1

16}, Francisco J Tinahones^{1

17}, José Lapetra^{1

18}, Lluís Serra-Majem^{1

19}, Naomi Cano-Ibañez^{14

20}, Vicente Martín-Sánchez^{21

22}, Xavier Pintó^{1

23}, José J Gaforio^{14

24}, Pilar Matía-Martín²⁵, Josep Vidal²⁶, Clotilde Vázquez^{1

27}, Lidia Daimiel²⁸, Emilio Ros^{1

29}, Carmen Sayon-Orea^{4

30}, Nerea Becerra-Tomás^{1

6}, Ignacio M Gimenez-Alba^{1

7}, Olga Castañer^{1

8}, Itziar Abete^{1

10}, Lucas Tojal-Sierra^{1

11}, Jéssica Pérez-López^{1

12}, Leyre Notario-Barandiaran^{13

14}, Antoni Colom^{1

3}, Antonio Garcia-Rios^{1

15}, Sara Castro-Barquero^{1

16}, Rosa Bernal^{1

17}, José M Santos-Lozano^{1

18}, Cesar I Fernández-Lázaro⁴, Pablo Hernández-Alonso^{1

6}, Carmen Saiz^{1

7}, Maria D Zomeño^{1

8}, Maria A Zulet^{1

10}, Maria C Belló-Mora^{1

11}, Javier Basterra-Gortari^{4

30}, Silvia Canudas^{1

6}, Albert Goday^{1

8}, Josep A Tur^{1

2

3}; PREDIMED-PLUS investigators

Collaborators, Affiliations

Collaborators

PREDIMED-PLUS investigators:
A J, L G-A, M A, Má M-G, J S-S, D C, M F, J A M, Ám A-G, J W, J Vioque, J L-M, R E, F J T, J L, L S-M, N C-I, V M-S, X P, J J G, P M-M, J Vidal, C V, L D, E R, C S-O, N B-T, I M G-A, O C, I A, L T-S, J P-L, L N-B, A C, A G-R, S C-B, R B, J M S-L, C I F-L, P H-A, C S, M D Z, M A Z, M C B-M, J B-G, S C, A G

Affiliations

¹ CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
² Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands, Palma de Mallorca, Spain.
³ Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.
⁴ Department of Preventive Medicine and Public Health, Navarra Health Research Institute (IDISNA), University of Navarra, Pamplona, Spain.
⁵ Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
⁶ Human Nutrition Unit, Biochemistry and Biotechnology Department, Pere Virgili Medical Research Institute (IISPV), Sant Joan University Hospital, University Rovira i Virgili, Reus, Spain.
⁷ Department of Preventive Medicine, University of Valencia, Valencia, Spain.
⁸ Unit of Cardiovascular Risk and Nutrition, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
⁹ Cardiometabolics Nutrition Program, Madrid Institute for Advanced Research (IMDEA) Food, Excellence International Campus, Autonomous University of Madrid and Higher Council of Scientific Research (CEI UAM + CSIC), Madrid, Spain.
¹⁰ Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain.
¹¹ Department of Cardiology, OSI ARABA, University Hospital Araba, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
¹² Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain.
¹³ Alicante Health and Biomedical Research Institute and Miguel Hernández University (ISABIAL-UMH),Alicante, Spain.
¹⁴ CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute (ISCIII), Madrid, Spain.
¹⁵ Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.
¹⁶ Department of Internal Medicine, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Clinic Hospital, University of Barcelona, Barcelona, Spain.
¹⁷ Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, Málaga, Spain.
¹⁸ Department of Family Medicine, Research Unit, Sevilla Primary Health Care District, Sevilla, Spain.
¹⁹ Institute for Biomedical Research, University of Las Palmas de Gran Canaria, Las Palmas, Spain.
²⁰ Department of Preventive Medicine, University of Granada, Granada, Spain.
²¹ CIBER Diabetes and Metabolic Diseases (CIBERDEM), Carlos III Health Institute (ISCIII), Madrid, Spain.
²² Institute of Biomedicine (IBIOMED), University of León, Leon, Spain.
²³ Lipids and Vascular Risk Unit, Internal Medicine, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain.
²⁴ Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, Jaen, Spain.
²⁵ Department of Endocrinology and Nutrition, San Carlos Hospital Health Research Institute (IdISSC), Madrid, Spain.
²⁶ Department of Endocrinology, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Clinic Hospital, University of Barcelona, Barcelona, Spain.
²⁷ Department of Endocrinology, Jiménez-Díaz Foundation, Madrid, Spain.
²⁸ Nutritional Control of the Epigenome Group, Precision Nutrition and Obesity Program, Madrid Institute for Advanced Research (IMDEA) Food, Excellence International Campus, Autonomous University of Madrid and Higher Council of Scientific Research (CEI UAM + CSIC), Madrid, Spain.
²⁹ Lipid Clinic, Department of Endocrinology and Nutrition, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Clinic Hospital, University of Barcelona, Barcelona, Spain.
³⁰ Navarra Health Service, Osasunbidea, Pamplona, Spain.

PMID: 33300039
DOI: 10.1093/jn/nxaa289

Free article

Randomized Controlled Trial

Metabolic Syndrome Features and Excess Weight Were Inversely Associated with Nut Consumption after 1-Year Follow-Up in the PREDIMED-Plus Study

Alicia Julibert et al. J Nutr. 2020.

Free article

. 2020 Dec 10;150(12):3161-3170.

doi: 10.1093/jn/nxaa289.

Authors

Collaborators

PREDIMED-PLUS investigators:
A J, L G-A, M A, Má M-G, J S-S, D C, M F, J A M, Ám A-G, J W, J Vioque, J L-M, R E, F J T, J L, L S-M, N C-I, V M-S, X P, J J G, P M-M, J Vidal, C V, L D, E R, C S-O, N B-T, I M G-A, O C, I A, L T-S, J P-L, L N-B, A C, A G-R, S C-B, R B, J M S-L, C I F-L, P H-A, C S, M D Z, M A Z, M C B-M, J B-G, S C, A G

Affiliations

¹ CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
² Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands, Palma de Mallorca, Spain.
³ Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.
⁴ Department of Preventive Medicine and Public Health, Navarra Health Research Institute (IDISNA), University of Navarra, Pamplona, Spain.
⁵ Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
⁶ Human Nutrition Unit, Biochemistry and Biotechnology Department, Pere Virgili Medical Research Institute (IISPV), Sant Joan University Hospital, University Rovira i Virgili, Reus, Spain.
⁷ Department of Preventive Medicine, University of Valencia, Valencia, Spain.
⁸ Unit of Cardiovascular Risk and Nutrition, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
⁹ Cardiometabolics Nutrition Program, Madrid Institute for Advanced Research (IMDEA) Food, Excellence International Campus, Autonomous University of Madrid and Higher Council of Scientific Research (CEI UAM + CSIC), Madrid, Spain.
¹⁰ Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain.
¹¹ Department of Cardiology, OSI ARABA, University Hospital Araba, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
¹² Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain.
¹³ Alicante Health and Biomedical Research Institute and Miguel Hernández University (ISABIAL-UMH),Alicante, Spain.
¹⁴ CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute (ISCIII), Madrid, Spain.
¹⁵ Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.
¹⁶ Department of Internal Medicine, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Clinic Hospital, University of Barcelona, Barcelona, Spain.
¹⁷ Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, Málaga, Spain.
¹⁸ Department of Family Medicine, Research Unit, Sevilla Primary Health Care District, Sevilla, Spain.
¹⁹ Institute for Biomedical Research, University of Las Palmas de Gran Canaria, Las Palmas, Spain.
²⁰ Department of Preventive Medicine, University of Granada, Granada, Spain.
²¹ CIBER Diabetes and Metabolic Diseases (CIBERDEM), Carlos III Health Institute (ISCIII), Madrid, Spain.
²² Institute of Biomedicine (IBIOMED), University of León, Leon, Spain.
²³ Lipids and Vascular Risk Unit, Internal Medicine, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain.
²⁴ Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, Jaen, Spain.
²⁵ Department of Endocrinology and Nutrition, San Carlos Hospital Health Research Institute (IdISSC), Madrid, Spain.
²⁶ Department of Endocrinology, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Clinic Hospital, University of Barcelona, Barcelona, Spain.
²⁷ Department of Endocrinology, Jiménez-Díaz Foundation, Madrid, Spain.
²⁸ Nutritional Control of the Epigenome Group, Precision Nutrition and Obesity Program, Madrid Institute for Advanced Research (IMDEA) Food, Excellence International Campus, Autonomous University of Madrid and Higher Council of Scientific Research (CEI UAM + CSIC), Madrid, Spain.
²⁹ Lipid Clinic, Department of Endocrinology and Nutrition, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Clinic Hospital, University of Barcelona, Barcelona, Spain.
³⁰ Navarra Health Service, Osasunbidea, Pamplona, Spain.

PMID: 33300039
DOI: 10.1093/jn/nxaa289

Abstract

Background: High nut consumption has been previously associated with decreased prevalence of metabolic syndrome (MetS) regardless of race and dietary patterns.

Objectives: The aim of this study was to assess whether changes in nut consumption over a 1-y follow-up are associated with changes in features of MetS in a middle-aged and older Spanish population at high cardiovascular disease risk.

Methods: This prospective 1-y follow-up cohort study, conducted in the framework of the PREvención con DIeta MEDiterránea (PREDIMED)-Plus randomized trial, included 5800 men and women (55-75 y old) with overweight/obesity [BMI (in kg/m2) ≥27 and <40] and MetS. Nut consumption (almonds, pistachios, walnuts, and other nuts) was assessed using data from a validated FFQ. The primary outcome was the change from baseline to 1 y in features of MetS [waist circumference (WC), glycemia, HDL cholesterol, triglyceride (TG), and systolic and diastolic blood pressure] and excess weight (body weight and BMI) according to tertiles of change in nut consumption. Secondary outcomes included changes in dietary and lifestyle characteristics. A generalized linear model was used to compare 1-y changes in features of MetS, weight, dietary intakes, and lifestyle characteristics across tertiles of change in nut consumption.

Results: As nut consumption increased, between each tertile there was a significant decrease in WC, TG, systolic blood pressure, weight, and BMI (P < 0.05), and a significant increase in HDL cholesterol (only in women, P = 0.044). The interaction effect between time and group was significant for total energy intake (P < 0.001), adherence to the Mediterranean diet (MedDiet) (P < 0.001), and nut consumption (P < 0.001). Across tertiles of increasing nut consumption there was a significant increase in extra virgin olive oil intake and adherence to the MedDiet; change in energy intake, on the other hand, was inversely related to consumption of nuts.

Conclusions: Features of MetS and excess weight were inversely associated with nut consumption after a 1-y follow-up in the PREDIMED-Plus study cohort. This trial was registered at isrctn.com as ISRCTN89898870.

Keywords: Mediterranean diet; PREDIMED-Plus study; excess weight; features of metabolic syndrome; lifestyle; metabolic syndrome; nut consumption; obesity; older adults; overweight.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ISRCTN Controlled Trials

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Metabolic Syndrome Features and Excess Weight Were Inversely Associated with Nut Consumption after 1-Year Follow-Up in the PREDIMED-Plus Study

Collaborators

Affiliations

Metabolic Syndrome Features and Excess Weight Were Inversely Associated with Nut Consumption after 1-Year Follow-Up in the PREDIMED-Plus Study

Authors

Collaborators

Affiliations

Abstract

Publication types

MeSH terms

Associated data

LinkOut - more resources

Full Text Sources

Medical

Research Materials

Miscellaneous